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Objectives This study sought to determine the prevalence, characteristics, and outcomes of asymptomatic left ventricular
(LV) systolic dysfunction in patients with severe aortic stenosis (AS).
Background Management of asymptomatic patients with severe AS remains controversial. In these patients, LV systolic dys-
function, defined in the guidelines as ejection fraction 50%, is a Class I(C) indication for aortic valve replace-
ment (AVR), but its prevalence is unknown.
Methods A retrospective study of adults 40 years of age with severe valvular AS (peak velocity 4 m/s, mean gradient
40 mm Hg, aortic valve area [AVA] 1 cm2, or AVA index 0.6 cm2/m2) from 1984 to 2010 was undertaken.
Patients with prior cardiac surgery, severe coronary artery disease, or greater than moderate aortic regurgitation
were excluded.
Results Of 9,940 patients with severe AS, 43 (0.4%) patients had asymptomatic LV dysfunction. Age was 73  14 years
and 70% were male. Hypertension (78%) and LV hypertrophy (LV mass index 143  36 g/m2) were characteris-
tic. Fifty-three percent of these patients developed symptoms at 21  19 months after diagnosis. During 7.5 
6.7-year follow-up, 5-year mortality was 48%. After multivariable adjustment, there was no survival advantage
with AVR in asymptomatic, severe AS with LV dysfunction (p  0.51).
Conclusions In severe AS, the prevalence of asymptomatic LV systolic dysfunction is 0.4%. Despite an asymptomatic clinical sta-
tus, patients with severe AS and LV ejection fraction 50% have a poor prognosis, with or without AVR.
(J Am Coll Cardiol 2012;60:2325–9) © 2012 by the American College of Cardiology Foundation
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.08.988y
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R
sManagement of the asymptomatic patient with severe aortic
stenosis (AS) remains controversial. Patients who receive an
aortic valve replacement (AVR) may have a better outcome
(1–3), though this may be impacted by the selection of
healthier patients for surgery. There is only 1 prospective
study of early versus late surgical intervention in asymptom-
atic, severe AS (4) and there are no randomized controlled
trials defining the optimal treatment strategy (5). According
to American College of Cardiology/American Heart Asso-
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accepted August 30, 2012.ciation (ACC/AHA) guidelines, left ventricular (LV) sys-
tolic dysfunction, defined as LV ejection fraction (LVEF)
50%, is a Class I(C) indication for AVR in severe,
asymptomatic AS (6,7). This recommendation is based on
very limited evidence.
It is unknown how often LV dysfunction develops in the
absence of symptoms in patients with severe AS. This study
was undertaken to determine the prevalence, clinical char-
acteristics, and outcomes of asymptomatic LV dysfunction
in patients with severe AS.
Methods
Study patients. A retrospective study of all adults 40
ears of age with severe valvular AS by a comprehensive
-dimensional and Doppler transthoracic echocardiogram
TTE) from 1984 to 2010 was performed after Institutional
eview Board approval. Severe AS was defined as a peak
ystolic velocity4 m/s, mean gradient40 mm Hg, aortic
alve area (AVA)1.0 cm2, or AVA index of0.6 cm2/m2
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Asymptomatic reduced LVEF in Severe Aortic Stenosis December 4, 2012:2325–9by Doppler echocardiography in
combination with 2-dimensional
echocardiographic appearance of
severe valvular AS (7). Only one
of these Doppler criteria of severe
AS was required for study inclu-
sion, thus ensuring that patients
with low-output, low-gradient se-
vere AS were included. Those
with LVEF 50% on an initial
qualifying TTE or subsequent
follow-up TTE in the absence of
prior AVR were reviewed for study
inclusion.
Exclusion criteria included:
1) prior cardiac surgery; 2) mul-
tivalvular heart disease or greater
than moderate aortic regurgita-
ion; 3) prior valvuloplasty; 4) severe coronary artery disease
y angiography (70% stenosis in 2 vessels); 5) prior
yocardial infarction; 6) congenital heart disease other than
icuspid AV; 7) cardiomyopathy; and 8) cardiac symptoms
pre-syncope, syncope, angina, exertional dyspnea, heart fail-
re, or resuscitated sudden cardiac death), with or without
tress testing. Stress testing was not routinely performed.
ontrol patients. Following identification of asymptom-
tic patients with severe AS and LVEF 50%, a 3:1
ge/gender/date matched–control group of asymptomatic
atients with severe AS meeting the same criteria except
aving LVEF 50% was performed.
tatistical analysis. Nominal variables are presented as
bsolute count and percentage of cohort. Continuous vari-
bles are presented as mean  SD. Categorical variables
ere compared between those with low LVEF and those
ith normal LVEF using chi-square tests. Continuous
ariables were compared between the groups using 2 sample
tests or nonparametric Wilcoxon rank sum tests. Paired t
ests were used to compare changes in echo parameters over
ime. The Kaplan-Meier method was used to construct
urvival curves using time of death as event time and last
nown follow-up as censoring time. A time-dependent
nalysis was conducted to determine the effect of AVR on
urvival. Cox proportional hazards regression modeling was
sed to determine multivariate associations with survival
nd estimate hazard ratios.
esults
revalence of asymptomatic LV dysfunction in severe
S. From 1984 to 2010, 9,940 patients undergoing TTE
nd clinical evaluation at our institution had severe valvular
S; 1,960 (20%) presented with LVEF 50% and 7,980
80%) had LVEF 50%. Excluding those who underwent
VR prior to follow-up TTE (n  2,225), 59% (3,388 of
,755) of patients had 1 or more follow-up TTEs per-
Abbreviations and
acronyms
ACC  American College of
Cardiology
AHA  American Heart
Association
AS  aortic stenosis
AV  aortic valve
AVA  aortic valve area
AVR  aortic valve
replacement
LV  left ventricle
LVEF  left ventricular
ejection fraction
TTE  transthoracic
echocardiogramormed: 14% (486 of 3,388) of these patients developed LVysfunction. Thus, a total of 2,446 (24.6%) patients pre-
ented with (n 1,960) or developed (n 486) LV systolic
ysfunction. Only 43 (1.8%) of the 2,446 patients had
solated severe AS and were asymptomatic, constituting
.4% of all patients with severe AS.
The 43 patients included 38 patients with asymptomatic,
evere AS and reduced LV function at the time of diagnosis,
nd 5 patients who developed asymptomatic LV dysfunc-
ion on follow-up TTE (range 6 to 44 months after
resenting TTE).
haracteristics of asymptomatic patients with severe AS
nd LVEF <50%. Of the 43 asymptomatic patients with
educed LV function, severe AS was identified in 40 (98%)
y AVA index, 34 (79%) by AV peak velocity, 31 (76%) by
VA, and 25 (64%) by AV gradient. Four patients met
evere AS criteria solely by AVA index. The clinical and
TE characteristics of the 43 patients compared with the
ge/gender/date matched–control group of asymptomatic
atients with severe AS and preserved LV function are
hown in Tables 1 and 2, respectively.
ymptoms and survival during follow-up. Figure 1 illus-
rates onset of symptoms and/or treatment with AVR in the
3 patients during 7.5  6.7 years of follow-up. Eighteen
atients developed cardiac symptoms, 12 remained asymp-
omatic until death, and 4 had indeterminate clinical status.
f those who developed symptoms, the average time from
ualifying TTE to onset of symptoms was 21  19 months
range 1 month to 5.6 years). Echocardiographic differences
efore and after onset of symptoms included AVA index
0.47  0.13 cm2/m2 vs. 0.41  0.12 cm2/m2, p  0.05),
V mean gradient (43  10 mm Hg vs. 56  13 mm Hg,
 0.02), and left atrial dimension (44  7 mm vs. 48 
7 mm, p  0.02).
Vital status could be determined in 42 patients (Fig. 1);
33 (79%) of 42 died. Five-year mortality in initially asymp-
tomatic unoperated patients with severe AS and LV dys-
function was 48% (Fig. 2). The cause of death was deter-
mined in 16 patients: 2 had sustained sudden, unexplained
deaths within 6 weeks of their last clinical encounter
without documented symptoms, 9 had cardiac death
(6 heart failure, 1 myocardial infarction, 1 post-AVR, and 1
during valvuloplasty), and 5 had noncardiac death.
AVR and outcomes. Aortic valve replacement was per-
formed in 25 (64%) of 39 patients in whom follow-up for
AVR was available (Fig. 1); concomitant coronary artery
bypass grafting was performed in 13 (52%), involving a
single vessel in 9 (70%). Seven asymptomatic patients
underwent AVR 3 months after their qualifying TTE, 13
developed symptoms prior to AVR and 5 asymptomatic
patients underwent late AVR.
Post-operative survival is presented in Figure 2. There was a
trend toward improved survival in patients undergoing AVR
(hazard ratio: 0.46, 95% confidence interval: 0.18 to 1.16, p
0.10), which was not present after adjustment for age, sex, and
time of diagnosis (1984 to 1995 vs. 1996 to 2010) (hazard
ratio: 0.77, 95% confidence interval: 0.36 to 1.67, p  0.51).
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December 4, 2012:2325–9 Asymptomatic reduced LVEF in Severe Aortic StenosisOf the 25 patients who underwent AVR, LVEF improved in
17 (81%) of the 21 with post-AVR TTEs.
Among the 14 patients who did not undergo AVR, 7
refused AVR despite physician recommendations, 4 were
advised against AVR by their physician due to comorbidities
or discordant clinical and echocardiographic interpretations
of AS severity, and 3 died while waiting for planned AVR.
Discussion
Prevalence and incidence of asymptomatic LVEF <50%
in severe AS. In this retrospective study of 9,940 adults
with severe AS, 2,403 (24%) patients had symptomatic LV
dysfunction. Asymptomatic LV dysfunction was present in
only 43 (0.4%) patients, including 38 who had LV dysfunc-
tion on presentation with severe AS, and 5 who developed
it during follow-up.
Current ACC/AHA guidelines recommend annual TTE
for patients with severe AS (7), allowing recognition of an
asymptomatic decline in LV systolic function. Herein we
Baseline Characteristics of Asymptomatic PatieLVEF <50% Versus Asymptomatic Patients WitTable 1 B seline Characteristics of AsympLVEF <50% Versus Asymptomatic P
Baseline and Clinical Characteristics
Asymptomat
With LV
(n 
Demographic characteristics
Age, yrs 73
Male 30 (
Body mass index, kg/m2 26.4
Assisted living 2 (
Historical medical comorbidities
Systemic hypertension 33 (
Smoking history 20 (
Atrial fibrillation 12 (
Hyperlipidemia 9 (
Diabetes mellitus 5 (
Cardiac procedures
Percutaneous coronary intervention 1 (
Medical therapy
Antiplatelet 16 (
Diuretic* 15 (
Digoxin† 10 (
Angiotensin-converting enzyme
inhibitor or receptor blocker*
10 (
Calcium-channel blocker* 9 (
Beta-blocker* 7 (
Coumadin 6 (
Statin 4 (
Nitrate 0 (
Electrocardiographic findings
LV hypertrophy 14 (
Left bundle branch block 4 (
Laboratory values
Hemoglobin, g/dl 13
Creatinine clearance, ml/min 61
Values are mean  SD or n (%). *For treatment of hypertension. †For
AS  aortic stenosis; LV  left ventricular; LVEF  left ventricular eshow that although it is uncommon, patients can develop dprogressive decline in LV function despite remaining
symptom-free.
Characteristics of patients with asymptomatic, severe AS
and LVEF <50%. AVA index 0.6 cm2/m2 was present
in 98% of our cohort. While parameters of AV mean
gradient and maximal velocity are impacted by LV
function and may create confusion in grading AS sever-
ity, the AVA index establishes AS severity relatively
independent of flow (8).
Compared to asymptomatic adults with severe AS and
LVEF 50%, those with reduced LV function were more
ikely to have a history of hypertension and echocardiographic
vidence of eccentric LV hypertrophic remodeling. While our
tudy was not powered to evaluate predictors of LV systolic
ysfunction, hypertension may be a poor prognostic factor in
evere AS. Pellikka et al. (9) and Hachicha et al. (10), in
ndependent studies of asymptomatic patients with severe AS
nd normal LV function, showed LV hypertrophy and in-
reased valvuloarterial impedance, respectively, to be indepen-
ith Severe AS andere AS and LVEF >50%ic Patients With Severe AS and
nts With Severe AS and LVEF >50%
vere AS
0%
Asymptomatic, Severe AS
With LVEF >50%
(n  122) p Value
73 13 0.941
86 (70%) 0.929
27.7 5.4 0.241
8 (7%) 0.644
74 (61%) 0.05
52 (43%) 0.659
20 (16%) 0.111
41 (34%) 0.105
14 (11%) 0.979
6 (5%) 0.441
49 (40%) 0.733
40 (33%) 0.802
22 (18%) 0.463
24 (20%) 0.621
20 (16%) 0.508
22 (18%) 0.709
7 (6%) 0.103
21 (17%) 0.194
5 (4%) 0.08
29 (24%) 0.120
2 (2%) 0.02
14 2 0.768
54 10 0.288
ent of atrial fibrillation or flutter.
fraction.nts Wh Sevomat
atie
ic, Se
EF <5
43)
 14
70%)
 3.9
4%)
78%)
47%)
28%)
21%)
12%)
2%)
37%)
35%)
23%)
23%)
21%)
16%)
14%)
9%)
0%)
37%)
11%)
 2
 28ent predictors of mortality.
left ven
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Asymptomatic reduced LVEF in Severe Aortic Stenosis December 4, 2012:2325–9Outcomes with asymptomatic LV dysfunction and severe
AS. The compensated clinical status and independent
functional status of asymptomatic patients with severe AS
and decreased LV systolic function provide false reassurance
for the underlying risk of morbidity and mortality. Within
our study group, 53% (18 of 34) of unoperated patients
developed symptoms within 2 years of their qualifying
Echocardiographic Characteristics of Asymptomand LVEF <50% Versus Asymp omatic PatientsTable 2 Echo ardiograph c Chara teristicsand LVEF <50% Versus Asymptoma
Echocardiographic Parameter
Asymptom
With
(n
Systolic blood pressure, mm Hg 13
LVEDD, mm 5
LV mass index, g/m2 14
Relative wall thickness 0.4
LVEF, % 4
Stroke volume index, ml/m2 4
Cardiac index, l/min/m2 3
AVA by continuity equation, cm2 0
AVA index, cm2/m2 0.4
AV peak systolic velocity, m/s 4
AV mean gradient, mm Hg 4
LA end systolic dimension, mm 4
E/e’ ratio 1
Mitral deceleration time, ms 21
Right ventricular systolic pressure, mm Hg 4
Valvuloarterial impedance, mm Hg·min/ml 4
Values are mean  SD.
AV  aortic valve; AVA  aortic valve area; LA  left atrial; LV 
ventricular ejection fraction.
Figure 1 Asymptomatic Adults With
Severe AS and LVEF <50% (n  43)
During follow-up of 7.5  6.7 years, 7 patients underwent early AVR and 2 of
43 patients died before scheduled follow-up. Of the remaining 34 patients, 18
developed symptoms, 12 remained asymptomatic, and 4 had indeterminate
symptom and surgical status. AS  aortic stenosis; AVR  aortic valve
replacement; LVEF  left ventricular ejection fraction.TTE; this rate was higher that reported by Pellikka et al. (9)
in patients with asymptomatic AS and any LVEF where
33% developed symptoms at 2 years.
The 5-year mortality rate for our asymptomatic adults
with severe AS and LV systolic dysfunction was substantial
at 48%. While AVR has previously been shown to be
beneficial in low-risk elderly patients with severe AS and in
symptomatic patients with LV dysfunction (11–13), our
study isolates, for the first time, asymptomatic patients with
reduced LV function. Although LVEF improved after AVR
Patients With Severe ASSevere AS and LVEF >50%ymptomatic Patients With Severe AS
atients With Severe AS and LVEF >50%
evere AS
50%
)
Asymptomatic, Severe AS
With LVEF >50%
(n  122) p Value
0 140 21 0.441
47 6 0.001
7 117 40 0.0008
.1 0.55 0.12 0.003
64 7 0.001
1 48 10 0.402
.9 3.3 0.7 0.258
.2 0.8 0.2 0.911
.1 0.44 0.1 0.389
.7 4.4 0.7 0.02
4 48 16 0.192
46 8 0.957
16 7 0.504
8 256 73 0.001
3 42 29 0.179
.3 4.0 0.9 0.137
tricle; LVEDD  left ventricular end-diastolic dimension; LVEF  left
Figure 2 Unadjusted Survival in Asymptomatic Adults
With Severe AS and LVEF <50%
During a median of 5.6 years follow-up, 33 of 42 patients died. After adjust-
ment for age, sex, and time period (1984 to 1995 vs. 1996 to 2010) of diag-
nosis, there was no survival benefit with AVR (p  0.51). Abbreviations as in
Figure 1.aticW thof As
tic P
atic, S
LVEF <
 43
5 2
4 7
5 3
6 0
3 6
3 1
.1 0
.8 0
3 0
.1 0
3 1
4 7
8 8
2 8
2 1
.6 1
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December 4, 2012:2325–9 Asymptomatic reduced LVEF in Severe Aortic Stenosisin these patients, survival was similar in patients with and
without AVR after adjustment for age, sex, and study date.
Study limitations. Given the retrospective method and
small sample size, caution must be exercised in the conclu-
sions drawn. Patients were deemed asymptomatic by review
of medical history alone; exercise testing was not required.
Coronary angiography was not performed in all patients and
52% who underwent AVR had concomitant coronary artery
bypass. Similarly, hypertension was a frequent comorbidity
and the combination of hypertension with severe AS may
have adversely impacted outcome. Serial TTEs were not
performed in all asymptomatic patients during follow-up.
Newer methods for detecting LV dysfunction, including
strain rate imaging (14), were not available.
Novel Study Conclusions
LV dysfunction may occur in patients with severe AS in the
absence of symptoms. However, it is uncommon: our study
defines the prevalence of asymptomatic LV dysfunction
occurring in patients with severe valvular AS at 0.4%.
Although 20% of patients with severe AS had LV dysfunc-
tion at presentation, the majority were symptomatic. While
infrequently encountered, the asymptomatic patient with
severe AS and LV dysfunction has a high risk of mortality,
even with AVR.
Current ACC/AHA guidelines offer limited recommen-
dations regarding management of asymptomatic patients
with severe AS. We show that the Class I(c) indication for
AVR in asymptomatic, severe AS, namely development of
LVEF 50%, is rarely applicable. However, mortality for
these patients is high—regardless of whether medical or
surgical management is employed. Further efforts are
needed to define the optimal time for AVR.
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